To find out whether HER-3872−886 peptide is presented on MHC class II molecules on the surface of tumor cells, we cocultured HER-3-reactive CD4 T cells and HLA-DR-matched HER-3-positive tumor cells, and measured IFN-γ production in the culture supernatants. Here, CD4 is linked to neoplasm.